Lowering LDL—not only how low, but how long?

Brown, Michael S., Goldstein, Joseph L.·2006·Science
DOI 10.1126/science.1125884

Cited by (204)

Items 101–200 of 204

  1. An update on the safety of nutraceuticals and effects on lipid parameters
    Arrigo F.G. Cicero, Alessandro Colletti · 2018 · Expert Opinion on Drug Safety
  2. A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases
    Bo Chen, Xin Shi, Yanping Cui, Aiping Hou, Pengjun Zhao · 2019 · Current Topics in Medicinal Chemistry
  3. My road to Damascus: how I converted to the prohormone theory and the proprotein convertases
    Michel Chrétien · 2012 · Biochemistry and Cell Biology
  4. PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering
    Bertrand Cariou, Zufeng Ding, Jawahar L. Mehta · 2016 · Atherosclerosis
  5. Developmental processes regulated by the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway: Highlights from animal studies
    Shahram Eisa-Beygi, Marc Ekker, Thomas W. Moon, R. Loch Macdonald, Xiao‐Yan Wen · 2014 · Reproductive Toxicology
  6. Niemann-Pick type C1 regulates cholesterol transport and metamorphosis in silkworm, Bombyx mori (Dazao)
    Xiaoxue Ke, Huijuan Chao, Muhammad Nadeem Abbas, Saima Kausar, Isma Gul, Haoyan Ji, Liqun Yang, Hongjuan Cui · 2020 · International Journal of Biological Macromolecules
  7. Maximizing the benefits of cholesterol-lowering drugs
    Kenneth R. Feingold · 2019 · Current Opinion in Lipidology
  8. Sterol Lipid Metabolism in Down Syndrome Revisited: Down Syndrome Is Associated with a Selective Reduction in Serum Brassicasterol Levels
    Gavin Tansley, Daniel Thomas Holmes, Dieter Lütjohann, Elizabeth Head, Cheryl Lea Wellington · 2012 · Current Gerontology and Geriatrics Research
  9. ESSENS dyslipidemia: A placebo-controlled, randomized study of a nutritional supplement containing red yeast rice in subjects with newly diagnosed dyslipidemia
    Kasliwal, Ravi R., Bansal, Manish, Gupta, Rajeev, Shah, Siddharth, Dani, Sameer, Oomman, Abraham, Pai, Vikas, Prasad, Guru Mallapa, Singhvi, Sunil, Patel, Jitendra et al. · 2016 · Nutrition
  10. PCSK9 inhibition and LDL cholesterol lowering: the biology of an attractive therapeutic target and critical review of the latest clinical trials
    David Rhainds, Benoît J. Arsenault, Jean‐Claude Tardif · 2012 · Clinical Lipidology
  11. LDL ‐c‐linked SNP s are associated with LDL ‐c and myocardial infarction despite lipid‐lowering therapy in patients with established vascular disease
    Anton P. van de Woestijne, Yolanda van der Graaf, Paul I. W. de Bakker, Folkert Wouter Asselbergs, Gert Jan de Borst, Ale Algra, Wilko Spiering, Frank L.J. Visseren, the SMART Study Group · 2013 · European Journal of Clinical Investigation
  12. A Softgel Dietary Supplement Containing Esterified Plant Sterols and Stanols Improves the Blood Lipid Profile of Adults with Primary Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Replication Study
    James M. McKenney, Belinda H. Jenks, Ed Shneyvas, James R. Brooks, Sonia F Shenoy, Chad M. Cook, Kevin Carl Maki · 2013 · Journal of the Academy of Nutrition and Dietetics
  13. Genetic determinants of plasma lipoproteins
    Rebecca L. Pollex, Robert Alexander Hegele · 2007 · Nature Clinical Practice Cardiovascular Medicine
  14. Phytonutrients of Bitter Apricot Seeds Modulate Human Lipid Profile and LDL Subfractions in Adults with Elevated Cholesterol Levels
    Jana Kopčeková, Anna Kolesárová, Marianna Schwarzová, Anton Kováčik, Jana Mrázová, Martina Gažarová, Petra Lenártová, Peter Chlebo, Adriana Kolesárová · 2022 · International Journal of Environmental Research and Public Health
  15. PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity
    Malak Alannan, Nabil Georges Seidah, Aksam J. Merched · 2022 · Cells
  16. Low-Density Lipoprotein Cholesterol: How Low Can We Go?
    Daniel P. Sherbet, Puja Garg, Emmanouil S. Brilakis, Subhash Banerjee · 2013 · American Journal of Cardiovascular Drugs
  17. Avances en el tratamiento de la hipercolesterolemia
    Juan Francisco Ascaso · 2010 · Endocrinología y Nutrición
  18. Cargo Receptor-Mediated ER Export in Lipoprotein Secretion and Lipid Homeostasis
    Xiao Wang, Xiaowei Chen · 2022 · Cold Spring Harbor Perspectives in Biology
  19. Phosphoethanolamine-complexed C-reactive protein: A pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum
    Sanjay K. Singh, Madathilparambil V. Suresh, Deborah Prayther, Jonathan P. Moorman, Antonio E. Rusiñol, Alok Chandra Agrawal · 2008 · Clinica Chimica Acta
  20. The Rationale for Initiating Treatment of Hypercholesterolemia in Young Adulthood
    Daniel Howard Steinberg · 2012 · Current Atherosclerosis Reports
  21. Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer prevention
    Shingo Miyamoto, Takumi Narita, Masami Komiya, Gen Fujii, Takahiro Hamoya, Ruri Nakanishi, Shuya Tamura, Yurie Kurokawa, Maiko Takahashi, Michihiro Mutoh · 2019 · Scientific Reports
  22. Evolution and Cholesterol
    Stanley Boyd Eaton · 2009 · World review of nutrition and dietetics
  23. Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals
    Scott M. Wasserman, Marc Steven Sabatine, Michael J. Koren, Robert Patrick Giugliano, Jason C. Legg, Maurice G. Emery, Sameer Doshi, Thomas Liu, Ransi M. Somaratne, John P. Gibbs · 2018 · Journal of Cardiovascular Pharmacology and Therapeutics
  24. Alirocumab for low-density Lipoprotein Cholesterol Lowering
    Eli M. Roth · 2018 · Future Cardiology
  25. A New Approach to Primary Prevention of Cardiovascular Disease
    John B. Kostis · 2007 · The American Journal of Medicine
  26. Statins for All?
    Scott M. Grundy · 2014 · The American Journal of Cardiology
  27. How Low an LDL-C Should We Go With Statin Therapy?
    William J. Kostis · 2014 · Current Atherosclerosis Reports
  28. Community pharmacies offer a potential high-yield and convenient arena for total cholesterol and CVD risk screening
    Karianne Svendsen, David R. Jacobs, Ida Tonning Røyseth, Kjersti W. Garstad, Marte Gjeitung Byfuglien, Linda Granlund, Lisa T Mørch-Reiersen, Vibeke H. Telle‐Hansen, Kjetil Retterstøl · 2018 · European Journal of Public Health
  29. Molecular imaging in atherosclerosis
    Ali Bassir, William Raynor, Peter Sang Uk Park, Thomas J. Werner, Abass A. Alavi, Mona-Elisabeth R. Revheim · 2022 · Clinical and Translational Imaging
  30. Effects of pcsk9 siRNA on THP-1 Derived Macrophages Apoptosis Induced by oxLDL*
    Lu-Shan Liu, Min XIE, Zhisheng Jiang, Qiong Yang, Li-Hong PAN, Chunyan Wu, Zhi‐Han Tang, Chao‐Ke Tang, Dang-heng Wei, Zuo Wang · 2009 · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS
  31. Evidence that Low Density Lipoprotein Is the Primary Cause of Atherosclerotic Cardiovascular Disease: A Bradford-Hill Approach
    David S. Schade, Deborah Helitzer, Philip Eaton · 2017 · World Journal of Cardiovascular Diseases
  32. Target discovery using biobanks and human genetics
    Michael A. Hicks, Claire Hou, Arya Iranmehr, Krisztina Marosi, Ewen F. Kirkness · 2019 · Drug Discovery Today
  33. The Legacy Effect in Treating Hypercholesterolemia
    John B. Kostis, Mrinali Shetty, Yuvraj Singh Chowdhury, William J. Kostis · 2020 · Journal of Cardiovascular Pharmacology and Therapeutics
  34. Another inconvenient truth: Combining the risks from obesity and metabolic syndrome with global warming
    Michael B. Clearfield · 2008 · Current Atherosclerosis Reports
  35. A comprehensive review on roles of electrochemical approaches in drug delivery
    Ali Reza Jalalvand, Mohammad Mehdi Karami · 2025 · Sensing and Bio-Sensing Research
  36. Guidelines for the Prevention of Symptomatic Cardiovascular Disease, Based upon the Presence of Coronary Artery Calcified Plaque—Provided by the Society for the Prevention of Symptomatic Heart Disease
    David S. Schade, S S Obenshain, Martin Hickey, Jennifer Febbo, Samuel Wann, Robert Philip Eaton · 2022 · World Journal of Cardiovascular Diseases
  37. Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization
    Aleyda Benitez‐Amaro, E. Garcia, Maria Teresa La Chica Lhoëst, A. Martínez, Carla Borràs, Mireia Tondo, María Virtudes Céspedes, Pablo Caruana, Antonietta Pepe, Brigida Bochicchio et al. · 2024 · Atherosclerosis
  38. Atherothrombotic comorbidity in the rheumatic diseases. The evidence becomes clearer. What should clinicians do?
    Inmaculada del Rincón · 2009 · Arthritis Care & Research
  39. Aggressive Management of Obesity in Children and Young Adults: The Known Challenges and Potential Opportunities
    Philip J. Barter, C.L. Shear · 2007 · Clinical Pharmacology & Therapeutics
  40. Starting early to control all risk factors in order to prevent coronary heart disease
    Henry C. McGill, Clyde Alex McMahan · 2010 · Clinical Lipidology
  41. Buffering of gene dosage response curves for human complex traits
    Nikhil Milind, Courtney J. Smith, Huisheng Zhu, Tamara Gjorgjieva, Jeffrey P. Spence, Jonathan K. Pritchard · 2026 · Cell Genomics
  42. Age‐Neutral Guidelines for the Primary Prevention of Cardiovascular Disease
    William J. Kostis, John B. Kostis · 2009 · Journal of Clinical Hypertension
  43. Atherosclerosis: Is a cure in sight?
    Don P. Wilson, Samuel S. Gidding · 2015 · Journal of clinical lipidology
  44. Treating Hypercholesterolemia and Hypertension Based on Lifetime Global Risk
    John B. Kostis · 2007 · The American Journal of Cardiology
  45. Regulation Of Hepatic Production Of Lipoproteins Containing Apolipoprotein B By ER-Associated Degradation
    Louis R. Lapierre, Roger S. McLeod · 2007 · Future Lipidology
  46. Treatment Targets in the Management of Dyslipidemias: Which Targets in Whom?
    Scott M. Grundy · 2012 · Current Cardiology Reports
  47. Genética de la hipercolesterolemia familiar
    Stoll, Mario, Dell’Oca, Nicolás · 2019 · Revista Uruguaya de Cardiología
  48. Hypocholesterolemic effects of plant sterols and stanols: Do the dose–response curves diverge?
    Kevin Carl Maki, Tia M. Rains · 2011 · Prostaglandins Leukotrienes and Essential Fatty Acids
  49. Statins and primary prevention: Is all the evidence in?
    Shirya Rashid, Gordon A. Francis · 2008 · Canadian Journal of Cardiology
  50. Molecular genetics for familial hypercholesterolemia
    Nicola Marziliano, Alessandro Medoro, Stefano Folzani, Mariano Intrieri, Claudio Reverberi · 2022 · Reviews in Cardiovascular Medicine
  51. Clinical trials report
    Michael B. Clearfield · 2007 · Current Atherosclerosis Reports
  52. Long-Term Exposure to High Low-Density Lipoprotein Cholesterol Levels and Clinical Course in Secondary Prevention After Coronary Artery Disease
    Ichiro Matsumoto, Kagari Mukaida, Kensaku Wada, Mizuki Kurozumi, Tsunetatsu Namba, Yuichiro Takagi · 2025 · Circulation Reports
  53. Association between the rs615563 variant of PCSK9 gene and circulating lipids and Type 2 diabetes
    Samira Taghizadeh Jazdani, Hajieh Bibi Shahbazian, Bahman Cheraghian, Mohammad Taha Jalali, Narges Mohammadtaghvaei · 2021 · BMC Research Notes
  54. Atherosclerosis, Vulnerable Plaques, and Acute Coronary Syndromes
    Jacob Fog Bentzon, Erling Falk · 2012 · Elsevier eBooks
  55. What do high blood resistin levels mean for patients on statin therapy?
    Shirya Rashid · 2013 · Expert Review of Cardiovascular Therapy
  56. Low-dose eicosapentaenoic acid and/or docosahexaenoic acid and triglyceride lowering
    Kevin Carl Maki, Tia M. Rains · 2010 · Nutrition Reviews
  57. Ten reasons to treat all individuals with a positive coronary artery calcium score
    David S. Schade, Allen Adolphe, James C. Blankenship, R. Philip Eaton · 2026 · The American Journal of Medicine
  58. Lipid Nephrotoxicity: New Concept for an Old Disease
    Xiong Zhong Ruan, Zac Varghese, J F Moorhead · 2014 · Springer eBooks
  59. Statin Therapy in Hyperlipidemia: Balancing the Risk and Benefits
    Kenneth R. Feingold · 2014 · The Endocrine Society eBooks
  60. Genetic and polygenic contributions to familial hypercholesterolemia in Thailand: Implications for diagnosis and lipid management
    Phongthana Pasookhush, Apinya Surawit, Sophida Suta, Sureeporn Pumeiam, Pichanun Mongkolsucharitkul, Bonggochpass Pinsawas, Suphawan Ophakas, Korapat Mayurasakorn · 2025 · Journal of clinical lipidology
  61. Genetic Risk Score Enables a Vaccine for Early Primary Prevention of CAD
    Robert Roberts · 2025 · Methodist DeBakey Cardiovascular Journal
  62. Biometric, nutritional, biochemical, and cardiovascular outcomes in male rats submitted to an experimental model of early weaning that mimics mother abandoning
    Rogério Barbosa de Magalhães Barros, Thaís Alvim-Silva, Júlia Raquel Nunes de Souza, Emiliana Barbosa Marques, Nazareth N. Rocha, Fernanda Brito, Christianne Brêtas Vieira Scaramello · 2020 · Journal of Developmental Origins of Health and Disease
  63. Proprotein Convertase PCSK9
    Nabil Georges Seidah · 2012 · Handbook of Proteolytic Enzymes
  64. Studies on PCSK9 in the regulation of cholesterol metabolism
    Lena Persson · 2011 · Figshare
  65. Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis
    Alok Chandra Agrawal · 2008 · Future Lipidology
  66. LDL cholesterol: should guidelines include targets?
    Subhash Banerjee, Dhiman Kahali, Avantika Banerjee, Emmanouil S. Brilakis · 2014 · Expert Review of Cardiovascular Therapy
  67. Clinical trials report
    Michael B. Clearfield · 2008 · Current Atherosclerosis Reports
  68. Comment on: “What Is Aging-Related Disease? An Epidemiological Perspective” by Le Couteur and Thillainadesan
    Timo E. Strandberg, Mika Kivimaki B · 2022 · The Journals of Gerontology Series A
  69. Lipid management in older patients
    Phil Mendys, Ross J. Simpson, Murrium I. Sadaf · 2016 · Cambridge University Press eBooks
  70. Pharmacometrics of Hyperlipidemia
    Maurice G. Emery, Peter C. Haughney, John P. Gibbs · 2014 · AAPS advances in the pharmaceutical sciences series
  71. ハイリスク・イノベーションにおける研究者ネットワークの役割 : 創薬における日米比較
    靖憲 馬場, ジョン・P ワルシュ · 2007 · 研究 技術 計画
  72. Mast cells and endothelial erosion: Implications for human atherothrombotic disease
    Mikko Ilari Mäyränpää · 2007 · Työväentutkimus Vuosikirja
  73. Therapeutic Lifestyle Change for the Prevention and Treatment of Hyperlipidemia and Coronary Artery Disease
    Rajesh Gupta, Bashar Almadani, Neil J. Stone · 2011 · Humana Press eBooks
  74. Emerging Therapeutic Approaches for Dyslipidemias Associated with High LDL and Low HDL
    Margrit Schwarz, Jae Bum Kim · 2011 · Wiley eBooks
  75. The Effects of Oats and Oat‐β‐Glucan on Blood Lipoproteins and Risk for Cardiovascular Disease
    Tia M. Rains, Kevin Carl Maki · 2013
  76. Cephalin: An effective ligand for LDL-C adsorbent
    Zhi Wang, Li Xu, Jian Jun Xie, Lingyun Jia · 2008 · Journal of Biotechnology
  77. Statins or Status Quo?
    Ragavendra R. Baliga, James B. Young · 2008 · Heart Failure Clinics
  78. Complexity in lipidology and the need for new intellectual instruments
    Marco Manca, Antonio Vittorino Gaddi · 2006 · Future Lipidology
  79. The effectiveness of blood cholesterol lowering is a question of duration as well as magnitude
    John C. Stanley · 2007 · Lipid Technology
  80. PCSK9 : un exemple de recherche translationnelle
    Michel Krempf, Bertrand Cariou, Philippe Costet · 2008 · Médecine des Maladies Métaboliques
  81. Musings on genome medicine: cholesterol and coronary artery disease
    David G. Nathan, Stuart H. Orkin · 2009 · Genome Medicine
  82. Associations between specific ApoE genetic variants and their interactions with environmental factors in relation to the lipid profile of black South Africans
    Lize Meades · 2014
  83. The E3 ubiquitin ligase c-IAP1 regulates PCSK9-mediated LDLR degradation: Linking the TNF-&x03B1; pathway to cholesterol uptake
    Weiming Xu, Lizhi Liu · 2010 · Nature Precedings
  84. National and international recommendations for the management of hyperlipidaemia
    2007 · CRC Press eBooks
  85. Heart-Healthy Diet
    S Sivasankaran · 2013 · CRC Press eBooks
  86. Lipid Management in Older Patients
    Phil Mendys, Ross J. Simpson, Jr. Ross J. Simpson · 2010 · Cambridge University Press eBooks
  87. Disorders of Lipid Metabolism
    Bodo Clemens Melnik · 2020 · Springer eBooks
  88. The Effect of Oat and Barley beta-glucan on LDL-C and Emerging Clinical Lipid Targets for Cardiovascular Disease
    Hoang Vi Thanh Ho · 2015 · TSpace (University of Toronto)
  89. Nuklearkardiologie
    Wolfgang Mohnike, G. Hör, Heinrich R. Schelbert · 2011 · Springer eBooks
  90. Summing up
    Daniel Howard Steinberg · 2007 · Elsevier eBooks
  91. iPSCs for modeling familial hypercholesterolemia type II A
    Jérôme Caron, Anne Dubart‐Kupperschmitt, Anne Weber · 2020 · Elsevier eBooks
  92. Lipids in Health and Disease
    Shoba Sujana Kumar, Karen A Lahey, Andrew G. Day, Stephen A. LaHaye · 2015
  93. Nuclear Cardiology — the Situation in Europe
    Wolfgang Mohnike, G. Hör, Heinrich R. Schelbert · 2008 · Springer eBooks
  94. Diet
    2007 · CRC Press eBooks
  95. Disorders of Lipid Metabolism
    Bodo Clemens Melnik · 2009 · Springer eBooks
  96. Lipid Management
    Phil Mendys, Adam Moskowitz, Ross J. Simpson · 2022 · Cambridge University Press eBooks
  97. Results of total cholesterol screening for early diagnosis of dyslipidemia in Saint Petersburg children
    A. A. Ivanilova, S. V. Eirikh, A. A. Korneva, A. M. Nikonenko, Tatiana M. Pervunina, E. S. Vasichkina · 2025 · Russian Journal for Personalized Medicine
  98. Additional file 1 of Association between the rs615563 variant of PCSK9 gene and circulating lipids and Type 2 diabetes
    Samira Taghizadeh Jazdani, Hajieh Bibi Shahbazian, Cheraghian, Bahman, Jalali, Mohammad Taha, Narges Mohammadtaghvaei · 2021 · Figshare
  99. Modulation pharmacologique et génétique de la fonctionnalité des particules HDL : Conséquences sur le risque cardiovasculaire et le développement de l'athérosclérose
    Petra El Khoury · 2014 · theses.fr (ABES)
  100. Genetic causes of cardiovascular disease : special focus on familial hypercholesterolemia and thoracic aortic aneurysms
    Sandy Elbitar · 2018 · theses.fr (ABES)